174 related articles for article (PubMed ID: 31427602)
1. Risk for pneumonia requiring hospitalization or emergency room visit according to delivery device for inhaled corticosteroid/long-acting beta-agonist in patients with chronic airway diseases as real-world evidence.
Park JH; Kim Y; Choi S; Jang EJ; Kim J; Lee CH; Yim JJ; Yoon HI; Kim DK
Sci Rep; 2019 Aug; 9(1):12004. PubMed ID: 31427602
[TBL] [Abstract][Full Text] [Related]
2. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
[TBL] [Abstract][Full Text] [Related]
3. Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β
Wittbrodt ET; Millette LA; Evans KA; Bonafede M; Tkacz J; Ferguson GT
Int J Chron Obstruct Pulmon Dis; 2019; 14():101-114. PubMed ID: 30613140
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of switching asthma patients from a Fixed-Dose Combination (FDC) Inhaled Corticosteroid [ICS]/Long-Acting Beta Agonist [LABA] therapy delivered by Dry Powder Inhaler (DPI) to ICS/LABA delivered by pressurised Metered Dose Inhaler (pMDI).
Al-Ahmad M; Webb D
Respir Med; 2022 Apr; 194():106771. PubMed ID: 35180515
[TBL] [Abstract][Full Text] [Related]
5. Does Changing Inhaler Device Impact Real-Life Asthma Outcomes? Clinical and Economic Evaluation.
Rhee CK; van Boven JFM; Yau Ming SW; Park HY; Kim DK; Park HS; Ling JZJ; Yoo KH; Price DB
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):934-942. PubMed ID: 30292924
[TBL] [Abstract][Full Text] [Related]
6. Real-life effectiveness of inhaler device switch from dry powder inhalers to pressurized metred-dose inhalers in patients with asthma treated with ICS/LABA.
Park HS; Yoon D; Lee HY; Ban GY; Wan Yau Ming S; Jie JLZ; Carter V; Hardjojo A; Van Boven JFM; Price DB
Respirology; 2019 Oct; 24(10):972-979. PubMed ID: 31038269
[TBL] [Abstract][Full Text] [Related]
7. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
[TBL] [Abstract][Full Text] [Related]
8. Incidence of oral thrush in patients with COPD prescribed inhaled corticosteroids: Effect of drug, dose, and device.
Dekhuijzen PNR; Batsiou M; Bjermer L; Bosnic-Anticevich S; Chrystyn H; Papi A; Rodríguez-Roisin R; Fletcher M; Wood L; Cifra A; Soriano JB; Price DB
Respir Med; 2016 Nov; 120():54-63. PubMed ID: 27817816
[TBL] [Abstract][Full Text] [Related]
9. Comparative Safety and Effectiveness of Inhaled Corticosteroid and Long-Acting β
Chang TY; Chien JY; Wu CH; Dong YH; Lin FJ
Chest; 2020 May; 157(5):1117-1129. PubMed ID: 31887282
[TBL] [Abstract][Full Text] [Related]
10. The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study.
Jones R; Martin J; Thomas V; Skinner D; Marshall J; Stagno d'Alcontres M; Price D
Int J Chron Obstruct Pulmon Dis; 2017; 12():2445-2454. PubMed ID: 28860739
[TBL] [Abstract][Full Text] [Related]
11. Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: Cohort Study in Real-World Clinical Practice.
Suissa S; Dell'Aniello S; Ernst P
Chest; 2020 Apr; 157(4):846-855. PubMed ID: 31759966
[TBL] [Abstract][Full Text] [Related]
12. Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).
Horita N; Goto A; Shibata Y; Ota E; Nakashima K; Nagai K; Kaneko T
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD012066. PubMed ID: 28185242
[TBL] [Abstract][Full Text] [Related]
13. Chronic Obstructive Pulmonary Disease Exacerbations and Pneumonia Hospitalizations Among New Users of Combination Maintenance Inhalers.
Feldman WB; Avorn J; Kesselheim AS; Gagne JJ
JAMA Intern Med; 2023 Jul; 183(7):685-695. PubMed ID: 37213116
[TBL] [Abstract][Full Text] [Related]
14. Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma.
Crossingham I; Turner S; Ramakrishnan S; Fries A; Gowell M; Yasmin F; Richardson R; Webb P; O'Boyle E; Hinks TS
Cochrane Database Syst Rev; 2021 May; 5(5):CD013518. PubMed ID: 33945639
[TBL] [Abstract][Full Text] [Related]
15. Risk of hospital admission or emergency room visit for pneumonia in patients using respiratory inhalers: a case-crossover study.
Lee CH; Jang EJ; Hyun MK; Lee NR; Kim K; Yim JJ
Respirology; 2013 Oct; 18(7):1116-27. PubMed ID: 23711281
[TBL] [Abstract][Full Text] [Related]
16. [Persistence to treatment by type of inhaler device in patients with asthma and chronic obstructive pulmonary disease].
Sicras A; Ferrer V; Collar JM; Navarro R; Sáez M
Semergen; 2017; 43(5):375-386. PubMed ID: 27425817
[TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness of Long-Acting Beta
Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405
[TBL] [Abstract][Full Text] [Related]
18. Dual-combination maintenance inhaler preferences in asthma and chronic obstructive pulmonary disease: A patient-centered benefit-risk assessment.
Tervonen T; Martinez FJ; Hanania NA; Heidenreich S; Eudicone JM; Gilbert I
Respir Med; 2021 Jan; 176():106278. PubMed ID: 33387985
[TBL] [Abstract][Full Text] [Related]
19. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
Nannini LJ; Lasserson TJ; Poole P
Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD006829. PubMed ID: 22972099
[TBL] [Abstract][Full Text] [Related]
20. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM; Culler SD; Ershoff D; Gutierrez B
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
